Company profile
Hemp, Inc
OTC: HEMP · Healthcare · Drug Manufacturers - Specialty & Generic
#1007 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 36
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), return on assets · ↓ growth stability, 3-yr revenue growth
Methodology →Revenue TTM
$184.4k
Rev growth YoY (TTM)
+333.7%
Net income (FY)
-$5.5M
Employees
5
as of 2026-08-26
Market cap
$883.0k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$184.4k$184.4k2022
Net income-$5.5M-$5.5M2022
Operating income-$3.3M-$3.3M2022
Total assets$44.3M$44.3M2022
Liabilities$31.2M$31.2M2022
Equity$13.2M$13.2M2022
Revenue trend
FY2015 – FY2022 · USD
FY15
FY16
FY17
FY18
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Hemp, Inc’s revenue?
Hemp, Inc booked $184.4k in FY2022 revenue, growing 334% year over year — faster than 92% of Healthcare companies we track, at a -2973.0% net margin.
Peers · Healthcare
CardioComm Solutions, Inc.25DBioxytran, Inc.27DaTyr Pharma, Inc.36DNuGen Medical Devices Inc.24DAbpro Holdings, Inc.14DPharmaRoth Labs, Inc.——Neighbors
Clark →Key facts
CEOGary Perlowin
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLas Vegas, NV
ExchangeOTC: HEMP
Employees5
IPO date2013-02-12
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.